Seismic Therapeutic
Cambridge, United States· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Total funding raised: $121M
Overview
A biotech using machine learning to intelligently design and optimize biologic drugs for autoimmune diseases.
ImmunologyAutoimmune Diseases
Technology Platform
The IMPACT platform integrates machine learning with immunology expertise to design and optimize biologic therapeutics, predicting key drug properties in silico.
Funding History
1Total raised:$121M
Series A$121M
Opportunities
Potential to dramatically accelerate and improve the success rate of developing novel, optimized biologic medicines for autoimmune conditions.
Risk Factors
Faces the risk that its machine learning models may not accurately predict clinical outcomes, and the high expectations placed on AI-driven biotechs.
Competitive Landscape
A leader in applying machine learning to immunology drug discovery, competing with both AI-native biotechs and established immunology players.